Could it be mould? The latest general research

If you’ve been told “it’s just anxiety”, “your labs are normal”, or “mould can’t do that” — you’re not imagining things.

Wider research into mould illness and CIRS is slow, controversial, and still evolving. But a few important shifts are happening. Some researchers are well ahead of the curve.

Here’s what’s broadly changing in mould research

• Researchers are increasingly finding measurable inflammatory markers in people with chronic mould exposure — including immune activation, vascular inflammation, and neuro-inflammation linked to fatigue, brain fog, pain, and poor stress tolerance

• There’s growing recognition that only some people get sick — genetic susceptibility and impaired toxin clearance likely play a role

• CIRS is being discussed alongside other immune-dysregulation conditions (like post-viral syndromes), rather than dismissed as “psychosomatic”

• New interest is emerging around objective testing (inflammation markers, neuro-cognitive changes, visual contrast sensitivity) — not just symptom checklists

• Treatment research is still early, but attention is shifting away from “kill and detox harder” toward reducing immune over-activation and ongoing exposure

What hasn’t changed (yet)

There is still no universally accepted diagnostic test, no gold-standard treatment, and limited large-scale trials. This is why so many people fall through the cracks of conventional care.

While the broader science is slowly moving from dismissal toward mechanism, there are ways to improve health naturally using diet and personalised supplement protocols to not just detox mould toxins, but deal with gut and fungal infections, rebalance the immune system, and deal with antibodies.